OSTEOARTHRITIS
Glucosamine sulphate for 12 months reduces relative risk of TJR at a 5 year follow-up
This report has been verified
by one or more authors of the
original publication.
Osteoarthritis Cartilage. 2008 Feb;16(2):254-60
275 patients were compiled from two initial studies that lasted 3 years to assess the effectiveness of glucosamine sulphate treatment in osteoarthritis (OA). This retrospective study included patients who had undergone treatment with placebo or glucosamine sulphate, 1500 mg once daily, between 12 and 36 months. Patients were followed-up 5 years following the cessation of the original study to determine the rate of total joint replacement (TJR). Results indicated that glucosamine sulphate treatment reduced the risk of TJR in patients with OA. The relative risk was 0.43 in comparison the patients on placebo treatment.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
